View by type:
Articles (4214)
Gavi helps immunise 65 million children in 2019, though COVID-19 puts progress under pressure
New analysis of WHO/UNICEF data by Gavi, the Vaccine Alliance, shows the gap in vaccine coverage between Gavi-supported lower-income countries and wealthier countries has shrunk to record lows
More people could be put at risk from yellow fever because of climate change
We already know that climate change could lead to yellow fever potentially spreading to new habitats in Europe and the USA. But now new research suggests that it may also increase in intensity across Africa, putting many thousands more people at…
COVAX Facility country consultations conclude with participation from at least 136 countries
Briefings led by Gavi, CEPI and WHO over the past two weeks saw participation from at least 136 countries interested in joining a COVAX Facility aimed at guaranteeing equitable access to eventual COVID-19 vaccines.
How are Gavi-supported countries maintaining routine immunisation during the pandemic?
A spotlight on Ethiopia, India, the Solomon Islands and Zambia
Governments have had to act fast to not only protect their people against COVID-19 but also to ensure protective measures like vaccination against other infectious diseases…
Why the UK wants to recruit half a million people in a COVID-19 vaccine trial
The UK has just secured 90 million doses of future COVID-19 vaccines, and now it is trying to recruit volunteers for some of the biggest ever phase 3 trials to test potential vaccines.
Delivering life-saving vaccines during the COVID-19 pandemic
Health workers are stopping at nothing to ensure immunizations for every child.
What happens if COVID-19 mutates?
Reports of a potentially more infectious form of the coronavirus have fed fears that a "mutant” version of the virus could arise. But what does mutation actually mean and is it really a cause for concern?
Should countries stop vaccinations to halt the spread of COVID-19?
It’s a devil’s choice governments have faced since the start of the pandemic, but new research could provide the answer.
Can the BCG vaccine protect against COVID-19?
While researchers racing to develop a COVID-19 vaccine, the potential of the BCG vaccine – used to prevent TB – to slow the pandemic has been hotly debated. New research suggesting that the BCG could prevent severe COVID-19 disease has made…
Could COVID-19 be airborne, and if so how do we protect ourselves?
Ever since the new coronavirus was identified, there has been a debate about whether it is airborne or not. Now, over 200 scientists from around the world have written to the World Health Organization urging it to consider the potential of COVID-…
The vaccines success story gives us hope for the future
As the world waits for a vaccine to defeat the COVID-19 pandemic, we look back to all that vaccines have achieved for humanity.
More than 150 countries engaged in COVID-19 vaccine global access facility
Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)